References
- Yusuf S, Zhao F, Mehta SR, Chrolavicius S, Tognoni G, Fox KK. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 2001;345:494-502. https://doi.org/10.1056/NEJMoa010746
- Mehta SR, Yusuf S, Peters RJ, et al. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet 2001;358:527-33. https://doi.org/10.1016/S0140-6736(01)05701-4
- Steinhubl SR, Berger PB, Mann JT 3rd, et al. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. JAMA 2002;288:2411-20. https://doi.org/10.1001/jama.288.19.2411
- Smith SC Jr, Allen J, Blair SN, et al. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute. Circulation 2006;113:2363-72. https://doi.org/10.1161/CIRCULATIONAHA.106.174516
- Wood S. HeartWire: mixed thoughts on how generic clopidogrel might impact patients, providers [Internet]. Montreal: theheart.org, 2006 [cited 2010 Mar 15]. Available from: http://www.theheart.org/article/729929.do.
- Gomez Y, Adams E, Hoogmartens J. Analysis of purity in 19 drug product tablets containing clopidogrel: 18 copies versus the original brand. J Pharm Biomed Anal 2004;34:341-8. https://doi.org/10.1016/S0731-7085(03)00533-8
- Kim SD, Kang W, Lee HW, et al. Bioequivalence and tolerability of two clopidogrel salt preparations, besylate and bisulfate: a randomized, open-label, crossover study in healthy Korean male subjects. Clin Ther 2009;31:793-803. https://doi.org/10.1016/j.clinthera.2009.04.017
- Bahrami G, Mohammadi B, Sisakhtnezhad S. High-performance liquid chromatographic determination of inactive carboxylic acid metabolite of clopidogrel in human serum: application to a bioequivalence study. J Chromatogr B Analyt Technol Biomed Life Sci 2008;864:168-72. https://doi.org/10.1016/j.jchromb.2008.01.049
- Colombo A, Orlic D, Stankovic G, et al. Preliminary observations regarding angiographic pattern of restenosis after rapamycin-eluting stent implantation. Circulation 2003;107:2178-80. https://doi.org/10.1161/01.CIR.0000070592.04766.36
- Applegate RJ, Grabarczyk MA, Little WC, et al. Vascular closure devices in patients treated with anticoagulation and IIb/IIIa receptor inhibitors during percutaneous revascularization. J Am Coll Cardiol 2002;40:78-83. https://doi.org/10.1016/S0735-1097(02)01924-1
- Cutlip DE, Windecker S, Mehran R, et al. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation 2007;115:2344-51. https://doi.org/10.1161/CIRCULATIONAHA.106.685313
- Di Girolamo G, Czerniuk P, Bertuola R, Keller GA. Bioequivalence of two tablet formulations of clopidogrel in healthy Argentinian volunteers: a single-dose, randomized-sequence, open-label crossover study. Clin Ther 2010;32:161-70. https://doi.org/10.1016/j.clinthera.2010.01.010
- Jeong YH, Koh JS, Kang MK, et al. The impact of generic clopidogrel bisulfate on platelet inhibition in patients with coronary artery stents: results of the ACCEL-GENERIC study. Korean J Intern Med 2010;25:154-61. https://doi.org/10.3904/kjim.2010.25.2.154
- Robinson A, Hillis J, Neal C, Leary AC. The validation of a bioanalytical method for the determination of clopidogrel in human plasma. J Chromatogr B Analyt Technol Biomed Life Sci 2007;848:344-54. https://doi.org/10.1016/j.jchromb.2006.10.076
- From AM, Al Badarin FJ, Cha SS, Rihal CS. Percutaneous coronary intervention with drug-eluting stents versus coronary artery bypass surgery for multivessel coronary artery disease: a meta-analysis of data from the ARTS II, CARDia, ERACI III, and SYNTAX studies and systematic review of observational data. EuroIntervention 2010;6:269-76. https://doi.org/10.4244/EIJV6I2A43
- Akin I, Bufe A, Schneider S, et al. Clinical outcomes in diabetic and non-diabetic patients with drug-eluting stents: results from the first phase of the prospective multicenter German DES.DE registry. Clin Res Cardiol 2010;99:393-400. https://doi.org/10.1007/s00392-010-0136-8
- Suh J, Park DW, Lee JY, et al. The relationship and threshold of stent length with regard to risk of stent thrombosis after drug-eluting stent implantation. JACC Cardiovasc Interv 2010;3:383-9. https://doi.org/10.1016/j.jcin.2009.10.033
- Applegate RJ, Sacrinty MT, Kutcher MA, Santos RM, Gandhi SK, Little WC. Effect of length and diameter of drug-eluting stents versus baremetal stents on late outcomes. Circ Cardiovasc Interv 2009;2:35-42. https://doi.org/10.1161/CIRCINTERVENTIONS.108.805630
- Weerakkody GJ, Brandt JT, Payne CD, Jakubowski JA, Naganuma H, Winters KJ. Clopidogrel poor responders: an objective definition based on Bayesian classification. Platelets 2007;18:428-35. https://doi.org/10.1080/09537100701206790
- Barragan P, Bouvier JL, Roquebert PO, et al. Resistance to thienopyridines: clinical detection of coronary stent thrombosis by monitoring of vasodilator-stimulated phosphoprotein phosphorylation. Catheter Cardiovasc Interv 2003;59:295-302. https://doi.org/10.1002/ccd.10497
- Muller I, Besta F, Schulz C, Massberg S, Schonig A, Gawaz M. Prevalence of clopidogrel non-responders among patients with stable angina pectoris scheduled for elective coronary stent placement. Thromb Haemost 2003;89:783-7.
- Katoh M, Nakajima M, Shimada N, Yamazaki H, Yokoi T. Inhibition of human cytochrome P450 enzymes by 1,4-dihydropyridine calcium antagonists: prediction of in vivo drug-drug interactions. Eur J Clin Pharmacol 2000;55:843-52. https://doi.org/10.1007/s002280050706
- Siller-Matula JM, Lang I, Christ G, Jilma B. Calcium-channel blockers reduce the antiplatelet effect of clopidogrel. J Am Coll Cardiol 2008;52:1557-63. https://doi.org/10.1016/j.jacc.2008.07.055
- Gremmel T, Steiner S, Seidinger D, Koppensteiner R, Panzer S, Kopp CW. Calcium-channel blockers decrease clopidogrel-mediated platelet inhibition. Heart 2010;96:186-9. https://doi.org/10.1136/hrt.2009.171488
Cited by
- Clustering of Acute and Subacute Stent Thrombosis Related to the Introduction of Generic Clopidogrel vol.19, pp.2, 2014, https://doi.org/10.1177/1074248413510605
- A Comparative In-Vitro Study for Evaluation of Physicochemical Properties of the Domestic and Innovator Brands of Sertraline Hydrochloride Tablets Available in the Iranian Market vol.23, pp.4, 2017, https://doi.org/10.15171/ps.2017.40